Clinical Trial Update: Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in untreated multiple myeloma patients with renal insufficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Renal Insufficiency

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Myeloma, Renal Insufficiency | Phase 2 | Status: COMPLETED